These results suggest that TGF-β, a factor highly expressed in the CC TME, may favor neoplastic progression by increasing adenosinergic activity mediated by tumor cells and the secretion of active CD39- and CD73-enriched EVs. This evidence concerns the gene NT5E and neoplasm.